F. Cao

发表

Phosphorothioate‑modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy.

Di Chen, Yuxin Shen, Huojun Zhang, 2017, Molecular medicine reports.

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

Yusheng Ye, T. Su, Xianzhi Zhao, 2020, Therapeutic advances in medical oncology.

Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles

Yusheng Ye, Xianzhi Zhao, Yuxin Shen, 2020, Cancer science.

Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2019, International journal of radiation oncology, biology, physics.

Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score).

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer management and research.

Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer medicine.

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis

Zhen Jia, Yuxin Shen, Huojun Zhang, 2019, Front. Oncol..

Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2016, BMJ Open.

Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer management and research.

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2017, Cancer medicine.

Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications

Di Chen, Xianzhi Zhao, Yuxin Shen, 2020, Cancer biology & medicine.

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases

Yuxin Shen, Huojun Zhang, Hongliang Xie, 2021, Frontiers in Oncology.